Argon laser trabeculoplasty in pigmentary glaucoma
- PMID: 8510905
- DOI: 10.1016/s0161-6420(93)31555-1
Argon laser trabeculoplasty in pigmentary glaucoma
Abstract
Purpose: To evaluate the long-term effect of argon laser trabeculoplasty (ALT) in pigmentary glaucoma.
Methods: The authors retrospectively analyzed results of ALT in 32 eyes of 32 patients with medically uncontrolled pigmentary glaucoma. Data were longitudinally adjusted to normalize the disparity in time of follow-up and evaluated by life-table analysis.
Results: Mean age (+/- standard deviation) was 45.1 +/- 13.1 years (range, 23-72 years) (males, 46.3 +/- 13.7 years; females, 42.9 +/- 12.2 years). Mean baseline intraocular pressure (IOP) was 27.8 +/- 5.3 mmHg. Mean follow-up time was 33.0 +/- 5.0 months (range, 1 week [immediate failures] to 96 months). Three eyes were lost to follow-up at 3 months. Eleven eyes required trabeculectomy between 1 week (2 eyes) and 37 months after laser treatment. Life-table analysis indicated a cumulative success for all eyes of 80% at 1 year, 62% at 2 years, and 45% at 6 years. Mean IOP was significantly reduced (P < 0.001; paired Student's t test) for male and female eyes at all intervals calculated. Age was a significant factor in determining time to failure.
Conclusion: Argon laser trabeculoplasty is effective in pigmentary glaucoma. Younger patients had a greater chance of success than older patients at all intervals. This became highly significant (P < 0.001) after 3 years.
Similar articles
-
Long-term efficacy of argon laser trabeculoplasty. A 10-year follow-up study.Ophthalmology. 1993 Sep;100(9):1324-9. doi: 10.1016/s0161-6420(93)31480-6. Ophthalmology. 1993. PMID: 8371919
-
Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma.Ophthalmology. 2004 Oct;111(10):1853-9. doi: 10.1016/j.ophtha.2004.04.030. Ophthalmology. 2004. PMID: 15465546
-
Micropulse diode laser (810 nm) versus argon laser trabeculoplasty in the treatment of open-angle glaucoma: comparative short-term safety and efficacy profile.Bull Soc Belge Ophtalmol. 2008;(308):21-8. Bull Soc Belge Ophtalmol. 2008. PMID: 18700451 Clinical Trial.
-
Long-term efficacy of repeat argon laser trabeculoplasty.Ophthalmology. 1991 Jul;98(7):1061-5. doi: 10.1016/s0161-6420(91)32176-6. Ophthalmology. 1991. PMID: 1891214 Review.
-
Argon laser trabeculoplasty five years on.Aust N Z J Ophthalmol. 1988 Nov;16(4):343-51. doi: 10.1111/j.1442-9071.1988.tb01240.x. Aust N Z J Ophthalmol. 1988. PMID: 3073798 Review.
Cited by
-
Pigment dispersion syndrome and pigmentary glaucoma: overview and racial disparities.Graefes Arch Clin Exp Ophthalmol. 2023 Mar;261(3):601-614. doi: 10.1007/s00417-022-05817-0. Epub 2022 Sep 10. Graefes Arch Clin Exp Ophthalmol. 2023. PMID: 36085315
-
A unification hypothesis of pigment dispersion syndrome.Trans Am Ophthalmol Soc. 1996;94:381-405; discussion 405-9. Trans Am Ophthalmol Soc. 1996. PMID: 8981706 Free PMC article. Review.
-
Membrane formation in the chamber angle after failure of argon laser trabeculoplasty: analysis of risk factors.Br J Ophthalmol. 2000 Jan;84(1):48-53. doi: 10.1136/bjo.84.1.48. Br J Ophthalmol. 2000. PMID: 10611099 Free PMC article.
-
Combined exfoliation and pigment dispersion: an overlap syndrome.Trans Am Ophthalmol Soc. 1999;97:297-314; discussion 314-21. Trans Am Ophthalmol Soc. 1999. PMID: 10703130 Free PMC article.
-
Baseline IOP predicts selective laser trabeculoplasty success at 1 year post-treatment: results from a randomised clinical trial.Br J Ophthalmol. 2005 Sep;89(9):1157-60. doi: 10.1136/bjo.2004.062414. Br J Ophthalmol. 2005. PMID: 16113372 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources